# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-097745
Filing Date
2024-04-16
Accepted
2024-04-16 16:10:21
Documents
68
Period of Report
2024-06-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d11454ddef14a.htm iXBRL | DEF 14A | 1697081
6 | GRAPHIC | g11454dsp026.jpg | GRAPHIC | 267063
7 | GRAPHIC | g11454dsp027.jpg | GRAPHIC | 300991
8 | GRAPHIC | g11454dsp028.jpg | GRAPHIC | 239592
9 | GRAPHIC | g11454dsp029.jpg | GRAPHIC | 230252
10 | GRAPHIC | g11454g00k01.jpg | GRAPHIC | 169388
11 | GRAPHIC | g11454g00k02.jpg | GRAPHIC | 116881
12 | GRAPHIC | g11454g00n17.jpg | GRAPHIC | 182333
13 | GRAPHIC | g11454g01a01.jpg | GRAPHIC | 37808
14 | GRAPHIC | g11454g01a05.jpg | GRAPHIC | 152692
15 | GRAPHIC | g11454g01a50.jpg | GRAPHIC | 43344
16 | GRAPHIC | g11454g01p04.jpg | GRAPHIC | 38411
17 | GRAPHIC | g11454g01r02.jpg | GRAPHIC | 134472
18 | GRAPHIC | g11454g02a03.jpg | GRAPHIC | 40998
19 | GRAPHIC | g11454g02a04.jpg | GRAPHIC | 41426
20 | GRAPHIC | g11454g02a05.jpg | GRAPHIC | 41228
21 | GRAPHIC | g11454g02a08.jpg | GRAPHIC | 40377
22 | GRAPHIC | g11454g02a09.jpg | GRAPHIC | 43293
23 | GRAPHIC | g11454g02a10.jpg | GRAPHIC | 43648
24 | GRAPHIC | g11454g02a12.jpg | GRAPHIC | 38949
25 | GRAPHIC | g11454g03p07.jpg | GRAPHIC | 207092
26 | GRAPHIC | g11454g03q58.jpg | GRAPHIC | 38330
27 | GRAPHIC | g11454g04p18.jpg | GRAPHIC | 48163
28 | GRAPHIC | g11454g05k04.jpg | GRAPHIC | 161096
29 | GRAPHIC | g11454g09a01.jpg | GRAPHIC | 123163
30 | GRAPHIC | g11454g09a02.jpg | GRAPHIC | 82599
31 | GRAPHIC | g11454g10a01.jpg | GRAPHIC | 215076
32 | GRAPHIC | g11454g10f90.jpg | GRAPHIC | 43767
33 | GRAPHIC | g11454g11a01.jpg | GRAPHIC | 193875
34 | GRAPHIC | g11454g12a01.jpg | GRAPHIC | 43569
35 | GRAPHIC | g11454g12a02.jpg | GRAPHIC | 75722
36 | GRAPHIC | g11454g12a03.jpg | GRAPHIC | 74877
37 | GRAPHIC | g11454g12a04.jpg | GRAPHIC | 88167
38 | GRAPHIC | g11454g12x01.jpg | GRAPHIC | 105292
39 | GRAPHIC | g11454g14e01.jpg | GRAPHIC | 25324
40 | GRAPHIC | g11454g21j47.jpg | GRAPHIC | 38792
41 | GRAPHIC | g11454g21r93.jpg | GRAPHIC | 24690
42 | GRAPHIC | g11454g22m16.jpg | GRAPHIC | 343909
43 | GRAPHIC | g11454g24k45.jpg | GRAPHIC | 41668
44 | GRAPHIC | g11454g24m24.jpg | GRAPHIC | 140701
45 | GRAPHIC | g11454g33g33.jpg | GRAPHIC | 55597
46 | GRAPHIC | g11454g34a02.jpg | GRAPHIC | 39635
47 | GRAPHIC | g11454g34a04.jpg | GRAPHIC | 38605
48 | GRAPHIC | g11454g35a01.jpg | GRAPHIC | 39771
49 | GRAPHIC | g11454g35c03.jpg | GRAPHIC | 39239
50 | GRAPHIC | g11454g39z49.jpg | GRAPHIC | 44256
51 | GRAPHIC | g11454g42d26.jpg | GRAPHIC | 40583
52 | GRAPHIC | g11454g46u95.jpg | GRAPHIC | 48789
53 | GRAPHIC | g11454g56t20.jpg | GRAPHIC | 98070
54 | GRAPHIC | g11454g57g57.jpg | GRAPHIC | 87683
55 | GRAPHIC | g11454g64q48.jpg | GRAPHIC | 115539
56 | GRAPHIC | g11454g71c34.jpg | GRAPHIC | 77885
57 | GRAPHIC | g11454g75v53.jpg | GRAPHIC | 47784
58 | GRAPHIC | g11454g88a88.jpg | GRAPHIC | 93064
59 | GRAPHIC | g11454g88b88.jpg | GRAPHIC | 85066
| Complete submission text file | 0001193125-24-097745.txt |  | 15857157

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20231231.xsd | EX-101.SCH | 5443
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20231231_def.xml | EX-101.DEF | 5435
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20231231_lab.xml | EX-101.LAB | 8079
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20231231_pre.xml | EX-101.PRE | 4857
71 | EXTRACTED XBRL INSTANCE DOCUMENT | d11454ddef14a_htm.xml | XML | 157389

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-16174 | Film No.: 24847914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)